ArticleJID innovations : skin science from molecules to population health2026
Development of a noninvasive device and method for measuring immune parameters in skin disease.
Article in JID innovations : skin science from molecules to population health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diagnosis, treatment, and monitoring of skin disease, including psoriasis and atopic dermatitis (AD), currently depend on clinical evaluation. Access to easily accessible and reliable biomarkers would facilitate diagnosis, treatment, and monitoring of disease activity. Currently used methods to collect biomarkers from the skin include taking biopsies, tape stripping, and collecting suction blister fluid. These methods cause discomfort and are not suitable for longitudinal monitoring. In this paper, we designed a skin wash device and method to noninvasively collect biomarkers from skin. We validated our device and method by application of recombinant cytokines on skin of healthy individuals. Thereafter, we determined the skin inflammatory profiles in patients with AD and patients with psoriasis and compared these with those of healthy control volunteers. We show that with our method, elevated concentrations of inflammatory cytokines were detected in samples obtained from patients with AD or psoriasis, and we were able to distinguish between these 2 patient groups on the basis of their cytokine profiles. We propose that our skin wash device and method is highly promising to improve the diagnostics, treatment, and monitoring of skin diseases. Furthermore, it could be used in other research areas leading to more insight in the (immune)pathogenesis of skin diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.